John Yee MD, MPH, currently serves as Senior Vice President, Medical Affairs, at Apnimed, Inc., a company developing oral pharmacologic treatments for obstructive sleep apnea based on repurposed drugs. He has more than 25 years of leadership experience at leading biotechnology, pharmaceutical, and health care technology companies, and at a major academic medical center. Dr. Yee has expertise in all aspects of drug development, including clinical development, medical affairs, pharmacovigilance, regulatory affairs, and patient advocacy. He has provided medical leadership for more than 10 new product launches and label expansions. Dr. Yee has served in senior medical leadership roles at Genzyme Corporation, AstraZeneca Pharmaceuticals, Intarcia Therapeutics, Vertex Pharmaceuticals, Flexion Therapeutics, and Sobi North America. Dr. Yee serves on the scientific advisory board for Comera Life Sciences, and previously served as a non-executive director on the board of directors. Dr. Yee earned an MD from Harvard Medical School, an MPH in Health Care Management from the Harvard T.H. Chan School of Public Health, and an AB in History and Science from Harvard College. He completed his pediatric residency and fellowship training in rheumatology, immunology and health services research at Boston Children’s Hospital. Prior to joining the industry, Dr. Yee held leadership roles at Boston Children’s Hospital and served as a faculty member at Harvard Medical School.

Arrow Shape Facebook Instagram Twitter Youtube Play Arrow Left